Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nektar Therapeutics - Common Stock
(NQ:
NKTR
)
43.22
+0.94 (+2.23%)
Streaming Delayed Price
Updated: 1:20 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nektar Therapeutics - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table
↗
December 28, 2025
When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.
Via
The Motley Fool
Topics
Regulatory Compliance
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away
↗
December 28, 2025
ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high.
Via
The Motley Fool
Topics
Regulatory Compliance
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know.
↗
November 20, 2025
Shares in the biotech company have surged on news of a big pharma takeover.
Via
The Motley Fool
Nektar Therapeutics (NASDAQ:NKTR) Q3 2025 Earnings Top Estimates, Sending Shares Higher
↗
November 06, 2025
Nektar Therapeutics (NKTR) Q3 2025 results beat analyst estimates for both revenue and earnings per share, sending the stock higher in after-hours trading.
Via
Chartmill
This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street
↗
October 13, 2025
Is it too late to get on the bandwagon?
Via
The Motley Fool
Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September
↗
October 05, 2025
Results of the Resolve-AD trial with rezpegaldesleukin were better than expected.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
↗
October 03, 2025
Via
Benzinga
These 2 Healthcare Stocks Are Up Over 100% in a Month. Can They Keep Climbing?
↗
September 21, 2025
Here's what needs to happen for these high flyers to continue soaring.
Via
The Motley Fool
Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today
↗
September 18, 2025
One of the company's pipeline drugs is showing significant promise.
Via
The Motley Fool
Why Is Nektar Therapeutics Stock Trading Lower On Thursday?
↗
September 18, 2025
Nektar reported Phase 2b results showing rezpegaldesleukin improved eczema severity scores and met primary and key secondary endpoints in patients.
Via
Benzinga
Why Nektar Therapeutics Rippled Higher This Week
↗
September 05, 2025
The company's competitive positioning might be stronger now, after disappointing results from a key rival.
Via
The Motley Fool
Topics
Intellectual Property
What's Going On With Nektar Therapeutics Stock On Thursday?
↗
September 04, 2025
Nektar Therapeutics stock is trading higher with no news, possibly due to Sanofi's disappointing results.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 04, 2025
Via
Benzinga
Shoe Carnival, American Eagle, Ciena, Victoria's Secret And Other Big Stocks Moving Higher On Thursday
↗
September 04, 2025
Via
Benzinga
Why Nektar Therapeutics Stock Popped 6% on Friday
↗
August 08, 2025
The company said it has sufficient financial resources to fund its operations into early 2027.
Via
The Motley Fool
Nektar (NKTR) Q2 Revenue Falls 52%
↗
August 08, 2025
Via
The Motley Fool
3 Bullish Biotech Stocks With Explosive Growth Trends
↗
July 21, 2025
These small-cap biotech stocks offer high-reward potential with bullish momentum and key catalysts ahead in urology, autoimmune, and gene editing therapies
Via
MarketBeat
Why Nektar Therapeutics Stock Dived by 3% Today
↗
July 03, 2025
Via
The Motley Fool
US Stock Futures Slip After Two Days Of Record Advances: 'FOMO Could Add Another 5%-10%...,' Says Expert
↗
July 01, 2025
U.S. futures slipped on Tuesday after two days of record-setting advances. Futures of major benchmark indices were trading lower.
Via
Benzinga
MSC Industrial Direct, Constellation Brands And 3 Stocks To Watch Heading Into Tuesday
↗
July 01, 2025
Via
Benzinga
Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains
↗
June 30, 2025
With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?
Via
MarketBeat
Nektar Jumps 157% on Drug Trial Data—Can It Go Even Higher?
June 28, 2025
Nektar Therapeutics soared 157% after Rezpeg succeeded in a Phase 2b eczema trial. Analysts forecast huge upside—here’s why there could be more gains ahead.
Via
MarketBeat
Nektar Nails Phase 2b Eczema Trial: BTIG Calls It A ‘Pound the Table BUY’, Wainwright Sees $120 Upside
↗
June 25, 2025
The data showed strong efficacy across multiple endpoints and consistent safety, reinforcing confidence in rezpegaldesleukin’s potential as a differentiated treatment for atopic dermatitis.
Via
Stocktwits
Why Nektar Therapeutics Stock Was Red-Hot Today
↗
June 25, 2025
Via
The Motley Fool
Why Is Nektar Therapeutics Stock Trading Higher On Wednesday?
↗
June 25, 2025
Nektar's rezpegaldesleukin met key efficacy targets in a mid-stage eczema study, though analysts flagged safety and differentiation concerns.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
June 25, 2025
Via
Benzinga
AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday
↗
June 25, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
